PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
YoungPlanet enables parents to put their children's unused things to use with new families and away from landfills for free via its app. The company cites PwC data estimating the UK’s sharing economy to be worth £9 billion by 2025. It aims to be a contender in this segment. The company argues further that 10-year-olds in the UK will own on average 238 toys at any one time and yet play with just 12. This leads to UK households wasting over 25 million tonnes a year, with one-fourth of this number ending up in landfills as per the Department for Environment, Food and Rural Affairs (DEFRA). YoungPlanet aims to change this. It has onboarded 36,000 users on its platform to date and featured in press publications such as BBC News, Vanessa Feltz, and LadBible. YoungPlanet will use the investment to scale nationally, begin generating first phase revenue via brand sponsorship of events, branded gamification, and Business-to-Business (B2B) subscriptions for semi-closed communities via its app.
days to go:
Expired
investment:
£547,103
Honestly Tasty is a plant-based cheese company known for our award-winning products available in M&S, Ocado, and other stores. Our aim is to cater to cheese enthusiasts who either avoid dairy or are reducing their dairy intake. By combining innovative ideas with traditional cheese-making methods, we create alternatives that stand out and spark positive conversations among consumers.
days to go:
Expired
investment:
£307,067
EarlyBird have created a number of different healthy snack packs, all made with fresh ingredients. EarlyBird deliver their snacks straight to your door meaning you don't have to leave the comfort of your home.
days to go:
Expired
investment:
£168,000
Erpingham House is the UK’s largest vegan restaurant whose aim is to make plant-based dining into the mainstream and provide delicious, healthy food and drinks to people. The company has earned nationwide recognition and, it has been listed in The Times top 20 vegetarian restaurants. It has also been featured in The Guardian and on channel 4’s “what Britain bought.” EH has served over 12,000 customers in its first year and, it has risen to over 20,000 followers on Instagram. The funds will be used to expand the brand & open a second site in Brighton.
days to go:
Expired
investment:
£192,280
Arro Money is a fast-growing money management company engaged in managing your money in a straightforward manner. Unlike traditional banking institutions, Arro uses exclusive technology that enables straightforward and hassle-free financial services. Through simple application, you can open personal or business accounts and manage your funds. Despite a few early-stage hiccups, the company has successfully opened over 42,000 accounts.
days to go:
Expired
investment:
£567,540
CoinBurp is a uniquely user-friendly crypto trading platform. It has a long-term vision to become an international brand and an integral part of the banking ecosystem. The company has acquired more than 1,000 users and facilitated 1000+ transactions, accumulating a trading volume of more than £1m. As CoinBurp enters its second phase of product development, it aims at providing banking facilities such as provide customers with prepaid cards, offer secured crypto loans and have initiated the process to become FCA regulated.
days to go:
Expired
investment:
£274,630
